WallStreetZenWallStreetZen

NYSE: EVMN
Evommune Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Evommune revenue was $13.00M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EVMN annual revenue was $13.0M, with 85.7% growth year-over-year.

EVMN past revenue growth

How has EVMN's revenue growth performed historically?

Company
85.71%
Industry
480.27%
Market
90.31%
EVMN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EVMN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EVMN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EVMN revenue history

Current Revenue
$13.0M
Current Earnings
-$68.9M
Current Profit Margin
-529.8%

Be the first to know when EVMN announces revenue.

EVMN Revenue History By Year

EVMN Yearly RevenueEVMN RevenueEVMN ChangeEVMN Revenue Growth
2025-12-31$13.00M$6.00M+85.71%
2024-12-31$7.00M$2.00M+40.00%
2023-12-31$5.00MN/AN/A

1 of 1

Evommune Revenue FAQ

What was EVMN's revenue last quarter?

On Invalid Date, Evommune (NYSE: EVMN) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Evommune's revenue was $0.00.

What was Evommune's revenue in 2025?

Evommune's annual revenue for the twelve months ending Dec 31, 2025 was $13.00 million, a 85.71% increase year over year.

How much does Evommune make in a day?

Based on Evommune annual revenue for the past two years, EVMN makes an average of $27,397.26 per day.

What was Evommune's annual revenue growth in the past year?

As of Q1 2026, Evommune's revenue has grown 85.71% year over year. This is 394.55 percentage points lower than the US Biotechnology industry revenue growth rate of 480.27%. Evommune's revenue in the past year totaled $13.00 million.

How much does Evommune make in a year?

Evommune's revenue by year for the past two years is:
  • Evommune's revenue for the twelve months ending Dec 31, 2025 was $13.00 million, a 85.71% increase year over year.
  • Evommune's annual revenue for Dec 31, 2024 was $7.00 million, a 40% increase from 2023.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.